<p>中国人寿 (02628.HK) +1.280 (+4.672%) 空头头寸 $497.98M; 比率 30.304% 今天开盘上涨 4.01%，一度达到 HKD29.18。目前交易价格为 HKD28.84，上涨 5.26%，成交量为 3845.31 万股，涉及金额为 11.07 亿港元。</p>
<p>在昨日市场收盘后，中国人寿公布了第一季度业绩。归属于母公司股东的净利润为人民币 195.05 亿元，同比下降 32.3%，基本每股收益为人民币 0.69。在此期间，营业收入同比下降 15.3%，为人民币 932.91 亿元。总保费收入同比增长 1.1%，达到人民币 3584.78 亿元。新业务价值激增 75.5%。</p>
<p>摩根大通表示，新业务价值的强劲增长抵消了盈利下降的负面影响，重申该股为行业首选，给予增持评级，目标价为 HKD40。</p>
<p>摩根士丹利表示，中国人寿第一季度新业务价值增长 76% 表现强劲，显著优于同行。尽管盈利下降 32%，但业绩仍略好于市场预期，业务质量持续改善。维持增持评级，目标价为 HKD37.9。（广告/用户）（香港股票报价延迟至少 15 分钟。空头数据截至 2026-04-29 16:25。）</p>
<p>本文由 AI 自动翻译，中文版本应视为权威版本。AASTOCKS.com Limited 不保证其准确性或完整性，并对因使用此翻译而产生的任何损害或损失不承担任何责任。</p>

中国人寿

<p>中国人寿的股票在发布第一季度业绩后上涨超过 5%，尽管净利润同比下降 32.3%，降至 195.05 亿元人民币。该公司报告的营业收入下降 15.3%，但总保费收入增长 1.1%。值得注意的是，新业务价值激增 75.5%。来自摩根大通和摩根士丹利的分析师对新业务价值的强劲增长表示赞赏，维持了超配评级，目标价格分别为 40 港元和 37.9 港元</p>

<p>CHINA LIFE (02628.HK) +1.280 (+4.672%)  Short selling $497.98M; Ratio 30.304%  opened 4.01% higher today and once peaked at HKD29.18. It is now trading at HKD28.84, up 5.26%, with 38.4531 million shares traded, involving HKD1.107 billion.</p>
<div class="lb-trans"><p>中国人寿 (02628.HK) +1.280 (+4.672%) 空头头寸 $497.98M; 比率 30.304% 今天开盘上涨 4.01%，一度达到 HKD29.18。目前交易价格为 HKD28.84，上涨 5.26%，成交量为 3845.31 万股，涉及金额为 11.07 亿港元。</p>
</div><p>After market close yesterday, CHINA LIFE announced its first-quarter results. Net profit attributable to shareholders of the parent company amounted to RMB19.505 billion, down 32.3% YoY, with basic EPS of RMB0.69. During the period, operating revenue declined 15.3% YoY to RMB93.291 billion. Total premium income rose 1.1% YoY to RMB358.478 billion. New business value surged 75.5%.</p>
<div class="lb-trans"><p>在昨日市场收盘后，中国人寿公布了第一季度业绩。归属于母公司股东的净利润为人民币 195.05 亿元，同比下降 32.3%，基本每股收益为人民币 0.69。在此期间，营业收入同比下降 15.3%，为人民币 932.91 亿元。总保费收入同比增长 1.1%，达到人民币 3584.78 亿元。新业务价值激增 75.5%。</p>
</div><p>JPM stated that the strong growth in new business value offset the negative impact of the earnings decline, reiterating the stock as a sector top pick with an Overweight rating and a TP of HKD40.</p>
<div class="lb-trans"><p>摩根大通表示，新业务价值的强劲增长抵消了盈利下降的负面影响，重申该股为行业首选，给予增持评级，目标价为 HKD40。</p>
</div><p>M Stanley said CHINA LIFE's 1Q new business value growth of 76% was robust and significantly outperformed peers. Despite a 32% drop in earnings, results were still slightly better than market expectations, with continued improvement in business quality. It maintained an Overweight rating with a TP of HKD37.9. (ad/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-29 16:25.)</p>
<div class="lb-trans"><p>摩根士丹利表示，中国人寿第一季度新业务价值增长 76% 表现强劲，显著优于同行。尽管盈利下降 32%，但业绩仍略好于市场预期，业务质量持续改善。维持增持评级，目标价为 HKD37.9。（广告/用户）（香港股票报价延迟至少 15 分钟。空头数据截至 2026-04-29 16:25。）</p>
</div><p>This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.</p>
<div class="lb-trans"><p>本文由 AI 自动翻译，中文版本应视为权威版本。AASTOCKS.com Limited 不保证其准确性或完整性，并对因使用此翻译而产生的任何损害或损失不承担任何责任。</p>
</div>

CHINA LIFE  Jumps Over 5% Post-Results; M Stanley and JPM Cite Strong 1Q New Business Value Growth

AASTOCKS News

摩根士丹利

摩根大通

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

中国人寿在业绩公布后股价上涨超过 5%；摩根士丹利和摩根大通指出其第一季度新业务价值增长强劲